Coming 2026: AI-Powered Precision Care for Women’s Chronic Gynecological Conditions
One Platform. One Unified Data Ecosystem. Complete Care and Research
ENDOless transforms lived experience into actionable health insights and research-grade data — supporting women with endometriosis, PCOS, PMS, chronic pelvic pain, and beyond.
Our privacy-first AI companion empowers women to better understand and manage their health, while generating the data science needs to finally understand women’s bodies.
The Crisis: A System That Doesn’t See Women
This is a crisis of data, diagnosis, and design — but most importantly, a crisis of trust and visibility
What women with endometriosis experience is not episodic pain.
Symptoms fluctuate, pain migrates, fatigue accumulates.
Yet the system captures only fragments, snapshots, and memories.
As a result, years pass without objective data,
and women are left to prove their pain again and again.
Endometriosis is not an exception.
It is the most visible example of a much broader failure
in how women’s health conditions are measured, tracked, and understood.
A diagnostic delay of nearly a decade is not a medical accident.
It is the consequence of tools designed without women’s lived physiology in mind.
When symptoms fluctuate, when pain is cyclical, when data is subjective —
systems that rely on snapshots will always fail.
From One Condition to a Systemic Failure
Endometriosis shares the same structural blind spots as many other conditions affecting women:
Across these conditions, the pattern is the same:
pain is cyclical, symptoms are multi-dimensional, and data is fragmented.
What changes is the diagnosis.
What doesn’t change is the system’s inability to see.
These are not edge cases.
They represent hundreds of millions of women worldwide, living with conditions that are under-measured, under-diagnosed, or entirely invisible to existing systems.
The issue is not rarity.
The issue is systemic neglect.
The cost of invisibility is not only pain —
it is accelerated risk.
Untreated or poorly managed gynecological conditions are associated with
higher rates of metabolic, cardiovascular, and mental health disorders.
Ignoring women’s health today creates chronic disease tomorrow.
Frequently Asked Questions
Frequently Asked Questions
When will ENDOless be available?
ENDOless is currently in beta and plans a full public launch in Q1 2026. Join our waitlist to get early access and help shape the product
How is ENDOless different from other period tracking apps?
ENDOless goes far beyond basic period tracking by focusing on chronic gynecological conditions like endometriosis and PCOS. Our AI-powered platform predicts flare-ups, delivers personalized insights, and generates research-grade, privacy-protected data to improve care and accelerate medical breakthroughs
What is ENDOless’s business model?
We operate on three revenue streams: a freemium subscription app for women (B2C), a SaaS platform for employers to support workforce wellbeing (B2B), and a Research-as-a-Service model licensing anonymized real-world data to pharma and academic researchers
How does ENDOless protect my data?
Privacy is at our core. ENDOless is built with GDPR-by-design principles, ensuring your health data is securely stored, anonymized, and only shared with your explicit consent. We never sell your data and comply with all global privacy regulations
Can I invest in or partner with ENDOless?
Absolutely! We welcome investors and partners aligned with our mission to revolutionize women’s health. Contact us via contact@endoless.app to learn more about collaboration opportunities
Who can use ENDOless?
ENDOless is designed for women with chronic gynecological conditions, employers aiming to improve employee wellbeing, and researchers seeking high-quality real-world data to drive innovation
Is ENDOless suitable for all women’s health conditions?
Our initial focus is on endometriosis, PCOS, PMS, and chronic pelvic pain, but we are building the platform to support a broad range of gynecological and autoimmune conditions over time